PrEP demand in England is rapidly accelerating – and most will want to join the trial
What marks out HIV controllers from others?
Why curing HIV may be like curing cancer – and may be as difficult
Can we achieve a complete HIV cure in more patients?
VRC01 antibody can delay but not prevent viral rebound after interruption of early treatment
Long-acting NRTI shows promise for HIV treatment and PrEP
Stillbirth more frequent in women with HIV in UK and Ireland than in general population
US HIV funding decisions on PEPFAR in 2017 will have critical effect on ability to reach 90-90-90 goals
First protease inhibitor combination pill maintains viral suppression
